全国统一24小时服务热线:400-0000-889400-0000-889  / 13999887799

热门新闻

当前位置:主页 > 热门新闻 >

China Sky One Medical, Inc. Receives Tax Refund

发布时间:2018-12-03 09:30 作者:AG88 来源:AG 点击: 字号:



HARBIN, China, Oct. 21 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), announced today that the Company's wholly-owned subsidiary, Harbin First Bio-Engineering Co. Ltd. ("Harbin First Bio-Engineering"), received $800,000 in tax savings from the Heilongjiang Binxi Economic Zone.

China Sky One Medical entered into an agreement with the Heilongjiang Binxi Economic Zone in 2005, when the Company decided to invest in Harbin First Bio-Engineering. Under the agreement, the Heilongjiang Binxi Economic Zone agreed to provide fiscal support by refunding local income taxes for Harbin First Bio-Engineering until 2010. As a result, Harbin First

Bio-Engineering received a 2007 local income tax refund of $800,000 in October, 2008.

"We are pleased to obtain local government fiscal support from the Heilongiang Binxi Economic Zone," said Mr. Yan-qing Liu, Chairman, CEO and President of China Sky One Medical. "We will invest this refund back into our business in order to further improve operations and carry out our growth strategy of strengthening our distribution channel and developing exciting new drugs."

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company, Harbin First Bio-Engineering Company Limited, and Heilongjiang Tianlong Pharmaceutical, Inc., the Company manufactures and distributes

over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.skyonemedical.com .

Safe Harbor Statement

Certain of the statements made in the press release constitute

forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding our future plans, objectives or performance. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

For more information, please contact:

Company Contact:

China Sky One Medical, Inc.

Mr. Yu-Bo Hao, Board Secretary

Tel: +86-451-5399-4069

Email: china_sky_one@yahoo.cn

Investor Relations Contact:

CCG Investor Relations

Mr. Crocerk Coulson, President

Tel: +1-646-213-1915

Email: crocker.coulson@ccgir.com

Web: http://www.ccgir.com

本文源自: 环亚娱乐

相关文章Related Articles

如果您觉得本站还不错,就请分享给身边的好友吧


分享成功还有机会获得精美礼品哦